# MannKind Corporation (NASDAQ: MNKD), Danbury, CT – FDA Inspections

Source: https://www.keypedia.com/companies/mannkind-corporation/b311f335-89a1-47a3-a7dc-24d2943cf1d4

> Inspection records and compliance data for MannKind Corporation in Danbury, Connecticut. 5 FDA inspections on record, last inspected November 04, 2025. Publicly traded as NASDAQ: MNKD.

---

## Details

- Name: MannKind Corporation
- FEI Number: 3005340341
- Address Line 1: 1 Casper St
- City: Danbury
- State: Connecticut
- Zip Code: 06810
- Country Name: United States
- Address: 1 Casper St, Danbury, Connecticut 06810, United States
- Country: United States

## Stock

- Stock ticker: MNKD
- Exchange: NASDAQ
- Share price: $4.16
- Market cap: $1.3B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1292892 - MannKind Corporation - 2025-11-04 — source: FDA, date: November 4, 2025
- [FDA Inspection 1292892 - MannKind Corporation - 2025-11-04](https://www.keypedia.com/records/fda_inspections/mannkind-corporation/64cfba93-d883-4aa9-bd1f-1db0cfd9446c) — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2025
- [483 - MannKind Corporation - 2021-08-06](https://www.keypedia.com/records/483/mannkind-corporation/686b387a-aa0f-4dfa-8b56-6f3748f18934) — source: FDA, date: August 6, 2021
- FDA Inspection 1148015 - MannKind Corporation - 2021-08-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 6, 2021
- FDA Inspection 1059556 - MannKind Corporation - 2018-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2018
- FDA Inspection 1059556 - MannKind Corporation - 2018-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2018
- [FDA Inspection 831784 - MannKind Corporation - 2013-05-17](https://www.keypedia.com/records/fda_inspections/mannkind-corporation/3e764528-d227-4656-b178-6aa90ee8206b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2013
- FDA Inspection 631965 - MannKind Corporation - 2009-12-04 — classification: No Action Indicated (NAI), source: FDA, date: December 4, 2009
- FDA Inspection 631965 - MannKind Corporation - 2009-12-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2009

## Related Companies

- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de)
- [Rubicon Research Private Limited](https://www.keypedia.com/companies/rubicon-research-private-limited/07d24fe7-deaa-4c5a-9fd3-9562d3cefd6f)
- [Applied Laboratories, Inc.](https://www.keypedia.com/companies/applied-laboratories-inc/f69dbcd4-a7e9-4a06-a09d-f7c9926508de)
- [Janssen Pharmaceutica, N.V.](https://www.keypedia.com/companies/janssen-pharmaceutica-nv/7ed39763-06a4-46b7-a9a1-76399c53844c)
- [Lilly France S.A.S.](https://www.keypedia.com/companies/lilly-france-sas/27fa7368-5fb0-48b1-b161-5729c7bfa061)
- [Holopack Verpackungstechnik GmbH](https://www.keypedia.com/companies/holopack-verpackungstechnik-gmbh/3e96b02f-23a1-4178-bf40-2e389739e0b0)
- [Allergan Pharmaceuticals Ireland](https://www.keypedia.com/companies/allergan-pharmaceuticals-ireland/b65756b6-b7d5-438c-a312-93abdd3b372d)
- [Liebel-Flarsheim Company LLC](https://www.keypedia.com/companies/liebel-flarsheim-company-llc/ca074473-a6a3-413d-828a-bee4671e7f97)
- [Sanofi S.r.l.](https://www.keypedia.com/companies/sanofi-srl/54ba861a-36eb-4486-a4ba-2a8194cdf7a5)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)

## Related Officers

- [Alexander V Gontcharov](https://www.keypedia.com/people/alexander-v-gontcharov/5059a8c2-c4f6-4b32-9aa4-c112a6444486)
- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170)
